Outcome of Board Meeting

A C C R E D I T E D ISO/IEC 17021 CERTIFICATION BODY Date: September 02, 2026 To To BSE Limited National Stock Exchange of India Limited 25th Floor, PJ Towers Exchange Plaza, C-1, Block G Dalal Street, Bandra Kurla Complex, Bandra (E) Mumbai – 400001 Mumbai – 400051 Scrip Code: 524654 Symbol: NATCAPSUQ Subject: Outcome of the Board Meeting held on Wednesday September 02, 2026 at Shorter Notice We wish to inform you that the Board of Directors of the Company at its meeting held today, Wednesday, September 02, 2026, inter- alia, considered and approved the following items: 1. Approved the Revised Price and Quantity of Equity Shares and Convertible Warrants of Preferential Issue: a. The Preferential Issue of up to 1,12,500 ( One Lakh Twelve Thousand five hundred Only) Equity Shares of Face Value of ₹10/- each ( Rupees Ten Only) to the person(s) belonging to the promoter /promoter group at an issue price of ₹178 (Rupees One Hundred Seventy Eight Only) price determined as per the SEBI (Issue of Capital and Disclosure Requirements) Regulation, 2018, subject to the approval of members in the General Meeting and other statutory and regulatory approvals whereas necessary and applicable. Further, the details as required under Regulation 30 of the Listing Regulations, 2015 read with SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026, is enclosed as Annexure A. b. The issuance of 4,50,000 (Four Lakh Fifty thousand only) Convertible Warrants each convertible into, 1 (one) fully paid- up equity share of the Company of face value of ₹10/- each ( Rupees Ten Only) to the person(s) belonging to the promoter/promoter group of the company, on a preferential basis (“ Preferential Issue”) at an issue price of ₹178/- ( Rupees One Hundred Seventy Eight Only) price determined as per the SEBI (Issue of Capital and Disclosure Requirements) Regulation, 2018, Minimum amount of ₹44.50/- (Rupees Forty-four and Fifty Paise Only) which is equivalent to 25% of warrant Issue Price shall be paid at the time of subscription and allotment of each warrant, Further subject to the approval of members in the General Meeting and other statutory and regulatory approvals whereas necessary and applicable. Further, the details as required under Regulation 30 of the Listing Regulations, 2015 read with SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026, is enclosed as Annexure A. The pricing and quantity have been revised in accordance with the Valuation Report dated August 31, 2026, issued by the Registered Valuer pursuant to queries raised by BSE & NSE and as per Chapter V of SEBI (ICDR) Regulations, 2018. 2. Approval of the Corrigendum Notice of Extra Ordinary General Meeting of the Members of the Company scheduled to be held on Wednesday, 9th September, 2026, at the registered office of the company to be dispatched on Wednesday, 2nd September, 2026. Reason for Shorter Notice & Inability for Prior 2-Day Intimation: The Valuation Report was received late on August 31, 2026, following queries raised by BSE & NSE. Due to the urgent necessity to dispatch the Corrigendum Notice by September 02, 2026, to meet statutory timelines, the Board Meeting had to be convened today, September 02, 2026, at Shorter Notice, making prior 2-working-days intimation under Regulation 29 non-feasible. Necessary consents for shorter notice were obtained from Directors pursuant to Section 173(3) of the Companies Act, 2013 and SS-1. The Board Meeting commenced at 9:00 AM and concluded at 11.00 AM. Kindly take the aforesaid information on record in compliance of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. Yours Faithfully, For Natural Capsules Limited Sunil L. Mundra Managing Director DIN: 00214304 A C C R E D I T E D ISO/IEC 17021 CERTIFICATION BODY Annexure-A The details as required to be disclosed under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Ci rcular No. HO/49/14/14(7)2025‐CFD‐POD2/I/3762/2026 dated January 30, 2026: Sl. Particulars Remarks 1. Type of 1. Equity Shares of face value ₹10/- each Securities proposed to be 2. Warrants convertible into Equity Shares of face value ₹10/- each i.e. 1 Equity issued (viz., Share per 1 Warrant. equity shares, convertibles etc.) 2. Type of Issuance Preferential issuance under Chapter V of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 3. Total number of 1. 1,12,500 (One Lakh Twelve Thousand five hundred) Equity Shares at issue price securities of ₹178/- per Equity Share aggregating to ₹2,00,25,000/- (Rupees Two Crores proposed to be Twenty five Thousand Only) to the persons belonging to Promoter/Promoter issued or the Group category. total amount for which the 2. 4,50,000 (Four Lakh fifty thousand) Warrants, convertible into equivalent securities will be number of equity shares at an issue price of ₹178/- per Equity Share (“Warrant issued Exercise Price”) aggregating to ₹8,01,00,000/- (Rupees Eight Crores one Lakh (approximately) Only) to the persons belonging to Promoter/Promoter Group category. 4. Additional details in case of preferential issue 4A. Name of the 1. Mr. Sunil L Mundra (Promoter/Promoter Group) – 1,12,500 Equity Shares. Investors - EQUITY 4B. Name of the 1. Mr. Sunil L Mundra (Promoter/Promoter Group) – 4,50,000 Warrants, Investors – convertible into equivalent number of equity shares. CONVERTIBLE WARRANTS 4C. Post allotment of Particulars Pre-Preferential Allotment *Post-Preferential Allotment securities - No. of shares %held No. of %held outcome of the held shares held subscription, Promoter/Promoter Group Category issue price / allotted price (in Mr. Sunil L 6,02,290 5.79% 11,64,790 10.61% case of Mundra convertibles), *Assuming full conversion of Warrants into equity shares number of investors. The post issue shareholding pattern has been prepared with shareholding as on 10th August, 2026, on the basis that the proposed allottees would have subscribed to all the warrants and have been allotted all the equity shares upon conversion of warrants. ₹178/- per Equity Share price determined as per the SEBI (Issue of Capital and Disclosure Requirements) Regulation, 2018 A C C R E D I T E D ISO/IEC 17021 CERTIFICATION BODY 4D. Issue Price – ₹178/- ( Rupees One Hundred Seventy Eight Only) Price determined as per the SEBI Equity & (Issue of Capital and Disclosure Requirements) Regulations, 2018 Convertibles Warrants 4E. In case of Each Warrant would be convertible into one equity share and the rights attached to the convertibles - Warrants can be exercised at any time within a period of 18 (Eighteen) months from the intimation on date of allotment of Warrants. conversion of An amount equivalent to 25% of the Warrant Exercise Price shall be payable at the time securities or on of subscription and allotment of each Warrant and the balance 75% of the Warrant lapse of the Exercise Price shall be payable by the Warrant holder against each Warrant at the time of tenure of the allotment of Equity Shares pursuant to exercise of the options attached to Warrant(s) to instrument subscribe to the Equity Share(s). The amount paid against Warrants shall be adjusted / set-off against the issue price for the resultant Equity Shares. In case the Warrant holder fails to exercise the Warrant within a period of 18 months from date of allotment of Warrant, the Warrant shall lapse and the 25% of the Warrant Exercise Price paid at the time of issuance of Warrant will be forfeited by the Company. 4F. Any Not applicable cancellation or termination of proposal for issuance of securities including reasons thereof. For Natural Capsules Limited Sunil L. Mundra Managing Director DIN: 00214304